Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.06 – $0.24
7% from low
Exchange
OTC Link
OS
LUMOS DIAGNOSTICS HLDGS
No one on the platform currently holds LDXHF.
No tracked institution reports a position in LDXHF as of their last filing.
No one on the platform has traded LDXHF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $21M | +61.4% | $-0.01 | $-0.01–$-0.01 | — | 1 |
| 2028 | $33M | +54.2% | $-0.01 | $-0.01–$-0.01 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-08-29 | $-0.07 | $-0.02 | +69.5% |
| 2023-02-23 | $-0.07 | $-4.37 | -6114.2% |
| 2022-08-26 | $-0.06 | $-0.32 | -439.7% |
| +0.00% |
| $241M |
| — |
| SHIEFShield Therapeutics plc | $0.07 | +0.00% | $75M | — |
| SNZZFSenzime AB (publ) | $0.39 | +0.00% | $61M | — |
Source: Financial Modeling Prep · peers by sector/industry